LACK OF A CORRELATION BETWEEN CELL-MEDIATED IMMUNITY TO THE CARRIER AND THE CARRIER-HAPTEN HELPER EFFECT

por Liew, F. Y., Parish, C. R.
Publicado 1974

IMMUNE RESPONSE TO CHEMICALLY MODIFIED FLAGELLIN : III. ENHANCED CELL-MEDIATED IMMUNITY DURING HIGH AND LOW ZONE ANTIBODY TOLERANCE TO FLAGELLIN

por Parish, C. R., Liew, F. Y.
Publicado 1972

An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice

por Magro, D.A.C., Hohmann, M.S.N., Mizokami, S.S., Cunha, T.M., Alves-Filho, J.C., Casagrande, R., Ferreira, S.H., Liew, F.Y., Cunha, F.Q., Verri, W.A.
Publicado 2013

Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice1

por Komai-Koma, M, Brombacher, F, Pushparaj, P N, Arendse, B, McSharry, C, Alexander, J, Chaudhuri, R, Thomson, N C, McKenzie, A N J, McInnes, I, Liew, F Y, Xu, D
Publicado 2012

IL-33 targeting attenuates intestinal mucositis and enhances effective tumour chemotherapy in mice

por Guabiraba, R, Besnard, A G, Menezes, G B, Secher, T, Jabir, M S, Amaral, S S, Braun, H, Lima-Junior, R C P, Ribeiro, R A, Cunha, F Q, Graham, G J, Teixeira, M M, Beyaert, R, Liew, F Y
Publicado 2014